M&A Deal Summary |
|
|---|---|
| Date | 2015-12-04 |
| Target | The Roberts Company |
| Sector | Construction |
| Buyer(s) | Argan |
| Sellers(s) |
Starboard Capital Partners
Main Street Resources Ironwood Capital |
| Deal Type | Add-on Acquisition |
| Deal Value | 500K USD |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1961 |
| Sector | Construction |
| Employees | 1,214 |
| Revenue | 573M USD (2024) |
Argan is a provider of engineering, procurement, construction, commissioning, maintenance, and consulting service. Argan energy plants include simple and combined cycle natural gas-fired power plants as well as alternative energy facilities including biodiesel, ethanol, and those powered by renewable energy sources such as wind and solar. Argan was founded in 1961 and is based in Rockville, Maryland.
| DEAL STATS | # |
|---|---|
| Overall | 5 of 5 |
| Sector (Construction) | 2 of 2 |
| Type (Add-on Acquisition) | 5 of 5 |
| State (North Carolina) | 1 of 1 |
| Country (United States) | 4 of 4 |
| Year (2015) | 2 of 2 |
| Size (of disclosed) | 3 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-05-12 |
Atlantic Projects Company
Singapore Atlantic Projects Company Ltd. is a provider of construction and technical services for power generation, oil & gas, industrial and process industry customers worldwide. |
Buy | - |
| Category | Private Equity Firm |
|---|---|
| Founded | 2004 |
| PE ASSETS | 700M USD |
| Size | Middle-Market |
| Type | Sector Agnostic |
Starboard Capital Partners LLC is an unsponsored investment group that works with private equity investors and management in acquiring mid-sized businesses valued between $25 and $100 million. In addition to investing, Starboard earns equity for initiating transactions and for ongoing advisory services. Sectors of interest include automotive, consumer products, building materials, construction, distribution, e-commerce, franchising, manufacturing, healthcare, and real estate. Starboard Capital was formed in 2004 and is based in Southport, Connecticut.
| DEAL STATS | # |
|---|---|
| Overall | 7 of 10 |
| Sector (Construction) | 4 of 4 |
| Type (Add-on Acquisition) | 4 of 7 |
| State (North Carolina) | 1 of 2 |
| Country (United States) | 7 of 10 |
| Year (2015) | 1 of 1 |
| Size (of disclosed) | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-06-29 |
QDiscovery
New London, Connecticut, United States QDiscovery LLC is a premier provider of electronic discovery and digital forensic services across the entire EDRM spectrum. QDiscovery LLC dedicated team of eDiscovery professionals, forensic experts, and litigation support specialists serves corporations, law firms, and government enterprises, helping them manage complex matters and reduce the expense of litigation. QDiscovery LLC single-source platforms allow clients to process and review faster, leverage advanced analytics, streamline workflows and automate complex productions, ultimately translating to lower costs. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-02-05 |
ESP/SurgeX
Knightdale, North Carolina, United States ESP/SurgeX is a manufacturer of power filtration and power protection technology for the office technology and mailing equipment industries. |
Sell | $130M |
| Category | Private Equity Firm |
|---|---|
| Founded | 1998 |
| Size | Small |
| Type | Sector Agnostic |
Main Street Resources is a private equity firm that targets controlling or minority investments in middle-market businesses located in the Northeast US. Main Street typically invests $2 to $10 million in companies with $10 to $75 million of revenue. Prospective transaction situations include privatizations, management buy-outs, the funding of growth capital and add-on acquisitions, and buyouts of passive or unproductive shareholders. Main Sreet will not invest in startups, technology companies or turnarounds. Main Street Resources was formed in 1998 and is based in Westport, Connecticut.
| DEAL STATS | # |
|---|---|
| Overall | 8 of 8 |
| Sector (Construction) | 3 of 3 |
| Type (Add-on Acquisition) | 3 of 3 |
| State (North Carolina) | 1 of 1 |
| Country (United States) | 7 of 7 |
| Year (2015) | 1 of 1 |
| Size (of disclosed) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-07-01 |
Glass America
Chicago, Illinois, United States Glass America conducts an automobile glass repair and replacement business in 22 states. |
Sell | - |
| Category | Growth Capital Firm |
|---|---|
| Founded | 1986 |
| PE ASSETS | 1.0B USD |
| Size | Middle-Market |
| Type | Sector Agnostic |
Ironwood Capital is a private investment firm that makes equity and subordinated debt investments in lower middle-market companies. Investment proceeds are generally used to support leveraged buyouts, growth financings, and recapitalizations. Investments typically range from $5 to $20 million in companies generating $20 to $200 million in annual sales. Target sectors include healthcare products/services, value-added manufacturing, business services, consumer products, specialty distribution, and education. Ironwood prefers opportunities East of the Mississippi, but will selectively consider investments in the Western US. The Firm's investment horizon is three to five years. Ironwood Capital was formed in 2002 and is based in Avon, Connecticut.
| DEAL STATS | # |
|---|---|
| Overall | 18 of 52 |
| Sector (Construction) | 1 of 2 |
| Type (Add-on Acquisition) | 13 of 32 |
| State (North Carolina) | 1 of 1 |
| Country (United States) | 18 of 52 |
| Year (2015) | 4 of 4 |
| Size (of disclosed) | 7 of 7 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-12-01 |
AxioMx
Branford, Connecticut, United States AxioMx, Inc. is a innovator of phage display antibody technologies and a leading provider of recombinant antibody development and production services. The current monoclonal and polyclonal antibody development paradigm is too slow and does not always result in consistent, renewable, and quality antibodies. Until recently the timelines and cost of phage display protocols have made the method impractical for most research and diagnostic reagent purposes. AxioMx’s innovative improvements to traditional phage display methods now make phage display a favored approach to antibody development for research, diagnostic, and therapeutic applications. |
Sell | $20M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-01-01 |
NovaTract
New Haven, Connecticut, United States NovaTract is a developer of a specialized, next-generation surgical tool, based upon technology licensed from Yale University. |
Sell | - |
